All In Biotech

Drug Trial Radar · NCT06425302

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

95

Actual

Start

Aug 30, 2024

Primary completion

Jun 19, 2026

Study completion Nov 27, 2028

Sponsor

Lead sponsor
CelgeneBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
May 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).

Conditions

  • Lymphoma, Follicular

Interventions

  • GolcadomideDrug

    Specified dose on specified days

  • RituximabDrug

    Specified dose on specified days

  • CyclophosphamideDrug

    Specified dose on specified days

  • DoxorubicinDrug

    Specified dose on specified days

  • VincristineDrug

    Specified dose on specified days

  • PrednisoneDrug

    Specified dose on specified days

  • BendamustineDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants who achieve complete metabolic response (CMR) as assessed by Lugano criteria 2014Time frame: Up to approximately 12 months from participant randomization

Locations

56 sites in 13 countries. Site status is shown where the registry gives one.

  • Local Institution - 0152

    Birmingham, Alabama

  • Local Institution - 0055

    Anchorage, Alaska

  • Local Institution - 0180

    Phoenix, Arizona

  • Local Institution - 0190

    Tucson, Arizona

  • Local Institution - 0035

    San Francisco, California

  • Local Institution - 0022

    Washington D.C., District of Columbia

  • Local Institution - 0209

    Fort Myers, Florida

  • Local Institution - 0005

    Jacksonville, Florida

  • Local Institution - 0210

    St. Petersburg, Florida

  • Local Institution - 0026

    Tampa, Florida

  • Local Institution - 0208

    West Palm Beach, Florida

  • Local Institution - 0019

    Westwood, Kansas

  • Local Institution - 0031

    Rochester, Minnesota

  • Local Institution - 0111

    Henderson, Nevada

  • Local Institution - 0183

    Hackensack, New Jersey

  • Local Institution - 0052

    Salt Lake City, Utah

  • Local Institution - 0201

    Norfolk, Virginia

  • Local Institution - 0202

    Seattle, Washington

  • Local Institution - 0046

    Liverpool, New South Wales, Australia

  • Local Institution - 0070

    South Brisbane, Queensland, Australia

  • Local Institution - 0181

    Traralgon, Victoria, Australia

  • Local Institution - 0060

    Rio de Janeiro, Brazil

  • Local Institution - 0058

    São Paulo, Brazil

  • Local Institution - 0056

    São Paulo, Brazil

  • Local Institution - 0061

    Porto Alegre, Rio Grande do Sul, Brazil

  • Local Institution - 0064

    Toronto, Ontario, Canada

  • Local Institution - 0205

    Chicoutimi, Quebec, Canada

  • Local Institution - 0049

    Santiago, Santiago Metropolitan, Chile

  • Local Institution - 0050

    Santiago, Santiago Metropolitan, Chile

  • Local Institution - 0118

    Paris, France

  • Local Institution - 0101

    Saint-Cloud, Hauts-de-Seine, France

  • Local Institution - 0103

    Lille, Nord, France

  • Local Institution - 0121

    Poitiers, Vienne, France

  • Local Institution - 0189

    Dresden, Germany

  • Local Institution - 0197

    Regensburg, Bavaria, Germany

  • Local Institution - 0188

    Chemnitz, Saxony, Germany

  • Local Institution - 0076

    Bologna, Italy

  • Local Institution - 0075

    Naples, Italy

  • Local Institution - 0198

    Rome, Lazio, Italy

  • Local Institution - 0179

    Rozzano, Milano, Italy

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.